We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Assayed Liquid Immunoassay Control Made Available

By LabMedica International staff writers
Posted on 16 Apr 2012
The Acusera Liquid Immunoassay Control is designed to be both easy and convenient to use and eliminates the need for reconstitution thus reducing the amount of human handling necessary and the subsequent risk of pipetting errors. More...


The recent inclusion of fully assayed target values and ranges for over 40 analytes enables laboratories to reduce the number of controls used and ultimately reduce costs and accurately assigned assayed target values are even provided for most immunoassay analyzers.

The combination of routine immunoassay analytes and a wide range of therapeutic drugs in a single liquid control material allows for increased efficiency across several areas of the clinical laboratory. As a true third party control, an unbiased, independent assessment of performance is guaranteed. Third Party is the term used to describe a control that has not been designed or optimized for use with a specific test or system. As such, they mirror the performance of patient samples and provide an unbiased, independent assessment of analytical performance.

The material is 100% human in origin providing a matrix similar to the patient sample but also reducing antibody interference and the possibility of control values shifting after changing reagent batch. Three clinically significant levels of control are available, supplied either separately or in a convenient and cost effective tri-level pack. A 5 mL vial size and open vial stability of seven days at 2-8 °C minimizes waste and helps to keep costs low.

The Acusera Liquid Immunoassay Control (Randox Laboratories Ltd; Crumlin, UK) is compatible for use with Acusera 24.7, a web based interlaboratory data management program. Users of Acusera 24.7 benefit from optimum performance and gain access to peer group data from laboratories worldwide. Peer group data is uniquely updated every 24 hours giving access to the most up to date information available.

Related Links:

Randox Laboratories Ltd.



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.